Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 6
2007 7
2008 4
2009 1
2011 5
2012 17
2013 13
2014 16
2015 22
2016 16
2017 25
2018 26
2019 8
2020 7
2021 7
2022 10
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Using the geriatric nutritional risk index to predict outcomes in older patients with remnant gastric cancer after gastrectomy: a retrospective multicenter study in Japan.
Matsunaga T, Saito H, Osaki T, Fukuda K, Fukumoto Y, Takahashi S, Taniguchi K, Iwamoto A, Kuroda H, Katano K, Shimizu S, Shishido Y, Miyatani K, Sakamoto T, Fujiwara Y. Matsunaga T, et al. Among authors: osaki t. Surg Today. 2024 Apr 23. doi: 10.1007/s00595-024-02850-w. Online ahead of print. Surg Today. 2024. PMID: 38652300
In vitro evaluation of the efficacy of photodynamic therapy using 5-ALA on homologous feline mammary tumors in 2D and 3D culture conditions and a mouse subcutaneous model with 3D cultured cells.
Lin S, Ota U, Imazato H, Takahashi K, Ishizuka M, Osaki T. Lin S, et al. Among authors: osaki t. Photodiagnosis Photodyn Ther. 2024 Feb;45:103993. doi: 10.1016/j.pdpdt.2024.103993. Epub 2024 Jan 26. Photodiagnosis Photodyn Ther. 2024. PMID: 38280675 Free article.
The prognostic impact of the lymphocyte-to-C-reactive protein ratio in patients with unresectable or recurrent advanced gastric cancer treated with first- and second-line treatment.
Matsunaga T, Saito H, Fukumoto Y, Kuroda H, Taniguchi K, Takahashi S, Osaki T, Iwamoto A, Fukuda K, Shimizu S, Shishido Y, Miyatani K, Fujiwara Y. Matsunaga T, et al. Among authors: osaki t. Surg Today. 2023 Aug;53(8):940-948. doi: 10.1007/s00595-022-02638-w. Epub 2023 Jan 3. Surg Today. 2023. PMID: 36595075
170 results